22 / 51
C o n t e n i d o d i s p o n i b l e e n h t t p : / / www. n e umo l o g i a - p e d i a t r i c a . cl
80
Neumol Pediatr 2016; 11 (2): 76 - 80
Actualización en displasia broncopulmonar
12. Palomino M, Morgues M, Martinez F. .Management of
infants with chronic lung disease of prematury in Chile. Early
Human Development 2005; 85, 143-149
13. Ola Didrik Saugstad, Dagfinn Aune. Optimal Oxyenation of
Extremely Low Birth Weight Infants: A Meta-Analysis and
Systematic Review of the Oxygen Saturation Target Studies.
Neonatol 2014;105:55–63
14. Stewart AB, Brion LP, Ambrosio-Perez I. Diuretics acting
on the distal renal tubule for preterm infants with (or
developing) chronic lung disease. Cochrane Database of
Systematic Reviews 2011, Issue 1.
15. Ng G, da Silva O, Ohlsson A. Bronchodilators for the
prevention and treatment of chronic lung disease in preterm
infants. Cochrane Database of Systematic Reviews 2012,
Issue 2
16. Updated Guidance for Palivizumab Prophylaxis Among
Infants and Young Children at Increased Risk of
Hospitalization for Respiratory Syncytial Virus Infection.
Pediatr 2014;134:415–420
17. Greenough A. Long term respiratory outcomes of very
premature birth (<32 weeks). Semin Fetal Neonatal Med
2012;17:73-6
18. Pérez G, Navarro M. Displasia broncopulmonar y
prematuridad. Evolución respiratoria a corto y largo plazo.
An Pediatr (Barc) 2010, 72: 79e1-79e16
19. Doyle L, Anderson P, Long-term outcomes of
bronchopulmonary dysplasia. Semin Fetal Neonatal Med
2009;14:391-395